愛德華生命科學EW
紐約證券 · USD
87.22
+0.62
(+0.72%)
收盤 10/20 03:59 (UTC+8)
盤後
87.01
87.01
(-0.24%)
10/20 03:59 (UTC+8)
愛德華生命科學EW
87.22
+0.62
(+0.72%)
財務數據
損益表
- 15.98
- 14.03
- 13.21
- 13.86
- 14.13
- 15.32
- 15.53
- 15.70
- 16.49
- 17.41
- -29.32
- -12.22
- -5.85
- 4.91
- 1.94
- 8.46
- 1.36
- 1.06
- 5.03
- 5.60
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 1,741,000 | 1,648,600 | 1,569,600 | 1,553,100 | 1,532,200 | 1,412,700 | 1,385,800 | 1,320,900 | 1,402,900 | 1,598,200 |
營業成本 | 392,400 | 362,600 | 343,000 | 345,200 | 344,400 | 301,600 | 292,200 | 243,700 | 294,700 | 385,600 |
營業毛利 | 1,348,600 | 1,286,000 | 1,226,600 | 1,207,900 | 1,187,800 | 1,111,100 | 1,093,600 | 1,077,200 | 1,108,200 | 1,212,600 |
營業費用 | 835,400 | 808,400 | 1,075,500 | 900,800 | 776,600 | - | 781,000 | - | - | - |
研發費用 | 278,900 | 263,300 | 267,700 | 280,700 | 276,200 | 254,600 | 271,100 | 251,500 | 273,700 | 285,200 |
推銷及管理費用 | 550,200 | 508,000 | 588,600 | 481,200 | 484,900 | 450,800 | 469,200 | 436,100 | 455,200 | 531,000 |
非經常性項目費用 | 6,300 | 37,100 | 219,200 | 138,900 | 15,500 | 10,900 | 40,700 | 43,700 | 8,100 | 8,900 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 513,200 | 477,600 | 151,100 | 307,100 | 411,200 | 394,800 | 312,600 | 345,900 | 371,200 | 387,500 |
其他收入及費用 | 6,600 | -18,600 | -40,300 | 41,300 | -11,000 | 39,100 | 97,300 | 52,200 | 17,500 | 21,900 |
利息費用 | - | - | 20,400 | - | - | - | 19,800 | - | - | - |
稅前純益 | 519,800 | 459,000 | 90,400 | 348,400 | 400,200 | 433,900 | 390,100 | 398,100 | 388,700 | 409,400 |
所得稅 | 278,400 | 78,300 | 26,200 | 56,100 | 64,300 | 70,300 | 45,100 | 40,200 | 20,500 | 58,400 |
稅後純益 | 241,900 | 380,700 | 91,200 | 291,100 | 333,200 | 358,000 | 385,600 | 3,070,800 | 366,300 | 351,900 |
基本每股稅後盈餘(元) | 0.42 | 0.66 | 0.16 | 0.50 | 0.57 | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 |
稀釋每股稅後盈餘(元) | 0.41 | 0.66 | 0.16 | 0.49 | 0.57 | 0.61 | 0.68 | 5.10 | 0.61 | 0.58 |
基本平均股數(千股) | 576400.00 | 579200.00 | 580400.00 | 584700.00 | 587000.00 | 586900.00 | 589800.00 | 597200.00 | 602100.00 | 601600.00 |
稀釋平均股數(千股) | 577600.00 | 580700.00 | 581800.00 | 585700.00 | 587900.00 | 587800.00 | 590500.00 | 598100.00 | 604300.00 | 604100.00 |
還原基本每股稅後盈餘(元) | 0.42 | 0.66 | 0.16 | 0.50 | 0.57 | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 |
還原稀釋每股稅後盈餘(元) | 0.41 | 0.66 | 0.16 | 0.49 | 0.57 | 0.61 | 0.68 | 5.10 | 0.61 | 0.58 |
還原基本平均股數(千股) | 576,400 | 579,200 | 580,400 | 584,700 | 587,000 | 586,900 | 589,800 | 597,200 | 602,100 | 601,600 |
還原稀釋平均股數(千股) | 577,600 | 580,700 | 581,800 | 585,700 | 587,900 | 587,800 | 590,500 | 598,100 | 604,300 | 604,100 |
EBITDA(千元) | 563,000 | 499,900 | 180,500 | 386,400 | 435,600 | 464,900 | 493,100 | 3,145,500 | 426,400 | 448,800 |